Reprogramming of lipid metabolism by ORF3a-induced microlipophagy enhances biogenesis of SARS-CoV-2 replication organelle
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013676 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Zhifei Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Hubei University, Wuhan, China. Hauptthemen laut MEDLINE: SARS-CoV-2, Lipid Droplets, Virus Replication, Lipid Metabolism. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hubei Provincial Key R&D Program, Natural Science Foundation of Wuhan.
Abstract (Originalsprache)
Infection by positive-strand RNA viruses necessitates membrane expansion and elevated phospholipid biosynthesis, whereby fatty acids stored as triacylglycerols in lipid droplets (LDs) are mobilized to promote metabolic processes and membrane biogenesis. The replication organelles (ROs) of coronavirus associate with modified host endomembrane; however, the molecular mechanisms underlying the expansion and modification of these membranes remain poorly understood. Here, we show that viral protein orf3a collaborates with nsp3, nsp4, nsp6 to facilitate the formation of ROs in SARS-CoV-2. Importantly, orf3a targets LDs to ROs, establishing novel membrane contact sites and induces host cell microlipophagy, which supplies essential lipids for RO biogenesis. Subsequently, Following the formation of ROs, nsp3, with assistance from nsp12, indirectly recruits phosphatidylinositol 4-kinase beta (PI4KB) to ROs, to produce phosphatidylinositol 4-phosphate (PI4P). This action creates a PI4P-enriched microenvironment that enhances SARS-CoV-2 replication. Our findings elucidate the mechanism governing RO generation during SARS-CoV-2 infection and suggest that targeting microlipophagy pharmacologically may represent a promising strategy for the development of anti-coronaviruses therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Hubei University, Wuhan, China.
- State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, China.
- State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan University, LuoJia Hill, Wuhan, China.
- Guangzhou Laboratory, Guangzhou, China.
- Hubei Jiangxia laboratory, Wuhan, China.
ORCID-Profile: Mingzhou Chen
Förderung
- National Natural Science Foundation of China
- Hubei Provincial Key R&D Program
- Natural Science Foundation of Wuhan
- Guangzhou National Laboratory
- the National Natural Science Foundation of China
- the Research Fund of Guangzhou National Laboratory
Zitieren
APA
Li, Z., Hui, X., Zheng, M., He, Z., Huai, W., Ding, B., Jin, M., Qin, Y., & Chen, M. (2025). Reprogramming of lipid metabolism by ORF3a-induced microlipophagy enhances biogenesis of SARS-CoV-2 replication organelle. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013676
Vancouver
Li Z, Hui X, Zheng M, He Z, Huai W, Ding B, et al. Reprogramming of lipid metabolism by ORF3a-induced microlipophagy enhances biogenesis of SARS-CoV-2 replication organelle. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013676
BibTeX
@article{Li2025,
author = {Li, Zhifei and Hui, Xianfeng and Zheng, Miaomiao and He, Zhicheng and Huai, Wenjing and Ding, Binbin and Jin, Meilin and Qin, Yali and Chen, Mingzhou},
title = {Reprogramming of lipid metabolism by ORF3a-induced microlipophagy enhances biogenesis of SARS-CoV-2 replication organelle},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013676}
}
EUVIMED